This week the FDA decided to revoke approval of the cancer drug Avastin for breast cancer patients. Although some breast cancer survivors credit Avastin for saving their lives, they are a minority of patients. And, according to the FDA, statistics don\’t show that the drug is significantly effective for the \”average patient.\”
This post was imported from a legacy archive. Please excuse any formatting inconsistencies.